$2.34
0.85%
Nasdaq, Sep 18, 11:53 am EDT. Market open.
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$2.36
+0.80 51.28% 1M
+0.28 13.46% 6M
-0.16 6.35% YTD
-0.56 19.18% 1Y
-6.44 73.18% 3Y
-34.84 93.66% 5Y
-19.56 89.23% 10Y
-1.50 38.80% 20Y
Nasdaq, Closing price Thu, Sep 17 2026
-0.01 0.42%

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$10.8m
Enterprise Value
$10.0m
Net debt
positive
Cash
$1.3m
Shares outstanding
3.2m
Valuation (TTM | estimate)
P/E
negative
P/S
2.4 | -
EV/Sales
2.3 | -
EV/FCF
negative
P/B
4.1
Financial Health
Equity Ratio
38.9%
Return on Equity
-143.5%
ROCE
-124.4%
ROIC
-127.5%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$4.5m | -
EBITDA
$-5.3m
EBIT
$-5.3m
Net Income
$-3.8m
Free Cash Flow
$-3.4m
Growth (TTM | estimate)
Revenue
-16.2% | -
EBITDA
-4.0%
EBIT
-3.6%
Net Income
23.9%
Free Cash Flow
11.9%
Margin
Gross
8.1%
EBITDA
-117.8%
EBIT
-119.5%
Net
-84.8%
Free Cash Flow
-76.9%
More
EPS
$-1.2
FCF per Share
$-1.1
Short interest
1.4%
Employees
54
Rev per Employee
$80.0k

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Biomerica, Inc.

May '26
+/-
%
4.45 4.45
16% 16%
100%
- Direct Costs 4.09 4.09
15% 15%
92%
0.36 0.36
28% 28%
8%
- Selling and Administrative Expenses 4.89 4.89
6% 6%
110%
- Research and Development Expense 0.79 0.79
23% 23%
18%
-5.25 -5.25
4% 4%
-118%
- Depreciation and Amortization 0.08 0.08
11% 11%
2%
EBIT (Operating Income) EBIT -5.32 -5.32
4% 4%
-120%
Net Profit -3.78 -3.78
24% 24%
-85%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
17 days ago
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2026 (“Fiscal 2026”).
Neutral
GlobeNewsWire
22 days ago
IRVINE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (“Biomerica” or the “Company”), a developer and manufacturer of diagnostic test systems, today announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the Company's common stock at a price of $1.60 per share, ex...
Neutral
GlobeNewsWire
4 months ago
Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capi...
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Mr. Irani
Employees 54
Founded 1971
Website biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today